Japanese (NIKKEI) Medical Equipment Industry Analysis

Industry Valuation and Performance

Has the Japanese Medical Equipment Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Sun, 02 Aug 2026	JP¥17.7t	JP¥5.8t	JP¥629.0b	16.3x	28.2x	3x
Tue, 30 Jun 2026	JP¥17.9t	JP¥5.8t	JP¥628.0b	15.9x	28.5x	3.1x
Thu, 28 May 2026	JP¥18.7t	JP¥5.8t	JP¥629.5b	14.3x	29.7x	3.2x
Sat, 25 Apr 2026	JP¥18.2t	JP¥5.7t	JP¥631.1b	14.3x	28.8x	3.2x
Mon, 23 Mar 2026	JP¥17.7t	JP¥5.7t	JP¥630.9b	15.2x	28.1x	3.1x
Wed, 18 Feb 2026	JP¥17.8t	JP¥5.7t	JP¥631.4b	15.4x	28.2x	3.1x
Fri, 16 Jan 2026	JP¥18.5t	JP¥5.8t	JP¥626.8b	16.4x	29.5x	3.2x
Sun, 14 Dec 2025	JP¥17.7t	JP¥5.8t	JP¥626.6b	15.7x	28.3x	3.1x
Tue, 11 Nov 2025	JP¥18.4t	JP¥5.7t	JP¥615.7b	15.1x	29.9x	3.2x
Thu, 09 Oct 2025	JP¥17.5t	JP¥5.7t	JP¥624.0b	15.9x	28x	3.1x
Sat, 06 Sep 2025	JP¥17.2t	JP¥5.7t	JP¥624.2b	16.7x	27.6x	3x
Mon, 04 Aug 2025	JP¥16.2t	JP¥5.7t	JP¥628.5b	16.5x	25.7x	2.8x
Wed, 02 Jul 2025	JP¥16.0t	JP¥5.7t	JP¥625.3b	15.8x	25.6x	2.8x
Fri, 30 May 2025	JP¥16.3t	JP¥5.7t	JP¥621.6b	15x	26.2x	2.9x
Sun, 27 Apr 2025	JP¥16.1t	JP¥5.7t	JP¥625.3b	15.4x	25.7x	2.8x
Tue, 25 Mar 2025	JP¥16.9t	JP¥5.7t	JP¥627.2b	15.9x	26.9x	3x
Thu, 20 Feb 2025	JP¥17.8t	JP¥5.7t	JP¥627.2b	16.3x	28.4x	3.1x
Sat, 18 Jan 2025	JP¥18.7t	JP¥5.5t	JP¥563.2b	15.3x	33.2x	3.4x
Mon, 16 Dec 2024	JP¥19.0t	JP¥5.5t	JP¥563.2b	15.6x	33.8x	3.4x
Wed, 13 Nov 2024	JP¥19.8t	JP¥5.5t	JP¥569.1b	15.8x	34.8x	3.6x
Fri, 11 Oct 2024	JP¥19.9t	JP¥5.4t	JP¥515.0b	19.1x	38.5x	3.6x
Sun, 08 Sep 2024	JP¥18.2t	JP¥5.4t	JP¥515.7b	16.9x	35.4x	3.4x
Tue, 06 Aug 2024	JP¥15.2t	JP¥5.3t	JP¥496.1b	13.6x	30.6x	2.9x
Thu, 04 Jul 2024	JP¥18.3t	JP¥5.3t	JP¥491.6b	15.5x	37.3x	3.5x
Sat, 01 Jun 2024	JP¥18.4t	JP¥5.4t	JP¥513.4b	15.6x	35.9x	3.4x
Mon, 29 Apr 2024	JP¥17.6t	JP¥5.3t	JP¥485.1b	17.3x	36.2x	3.3x
Wed, 27 Mar 2024	JP¥18.3t	JP¥5.3t	JP¥485.2b	18.3x	37.8x	3.5x
Fri, 23 Feb 2024	JP¥18.6t	JP¥5.3t	JP¥485.2b	16.5x	38.2x	3.5x
Sun, 21 Jan 2024	JP¥18.2t	JP¥5.2t	JP¥509.6b	18.1x	35.7x	3.5x
Tue, 19 Dec 2023	JP¥17.0t	JP¥5.2t	JP¥510.0b	17.3x	33.3x	3.2x
Thu, 16 Nov 2023	JP¥16.7t	JP¥5.2t	JP¥499.6b	17.2x	33.5x	3.2x
Sat, 14 Oct 2023	JP¥15.4t	JP¥5.1t	JP¥563.7b	17.1x	27.4x	3x
Mon, 11 Sep 2023	JP¥16.2t	JP¥5.1t	JP¥563.4b	17.4x	28.8x	3.2x
Wed, 09 Aug 2023	JP¥17.3t	JP¥5.1t	JP¥573.5b	16.7x	30.1x	3.4x

Current Industry PE

Investors are relatively neutral on the Japanese Medical Equipment industry at the moment, indicating that they anticipate long term growth rates to remain steady.

The industry is trading close to its 3-year average PE ratio of 31.0x.

The industry is trading close to its 3-year average PS ratio of 3.2x.

Past Earnings Growth

The earnings for companies in the Medical Equipment industry have grown 3.2% per year over the last three years.
Revenues for these companies have grown 4.5% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?


JP Market	-0.42%
Healthcare	-1.45%
Medical Equipment	2.84%
Medical Equipment	5.47%
Medical Supplies	0.95%

Industry PE

Investors are most optimistic about the Medical Supplies industry even though it's trading below its 3-year average PE ratio of 34.4x.

Analysts are expecting annual earnings growth of 9.0%, which is higher than its past year's earnings growth of 3.9% per year.

Investors are most pessimistic about the Medical Equipment industry, which is trading below its 3-year average of 28.4x.

Forecasted Growth

Analysts are most optimistic on the Medical Equipment industry, expecting annual earnings growth of 13% over the next 5 years.
This is better than its past earnings decline of 0.2% per year.

In contrast, the Medical Supplies industry is expected to see its earnings grow by 9.0% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company	Last Price	7D	1Y	Valuation
4543 Terumo	JP¥2.32k	7.4% +JP¥235.3b	-9.3%	PE25.2x
7733 Olympus	JP¥1.82k	5.2% +JP¥96.1b	-0.2%	PE28.4x
7747 Asahi Intecc	JP¥3.59k	6.3% +JP¥56.8b	50.7%	PE31.1x
6869 Sysmex	JP¥1.60k	4.5% +JP¥41.8b	-35.5%	PE27.3x
7741 HOYA	JP¥24.68k	0.5% +JP¥38.5b	41.0%	PE30.9x

Olympus Corporation Announces Management Changes, Effective August 1, 2026

Olympus Corporation announced that the Board of Directors resolved to change the Executive Officer and Chief Quality Officer, effective August 1, 2026. Reason for change of Executive Officer: Boris Shkolnik led the establishment of the global quality function and system as Olympus, strengthened its position as a global medtech company. During this transformation, he enhanced engagement with the FDA, advanced the Quality Management System to improve global standardization and audit readiness, designed and established global Quality and Regulatory Affairs functions and drove the adoption of a patient safety and quality culture across the organization. His leadership helped establish a stronger foundation for quality and regulatory compliance. To support strategic growth investments, remain committed to proactive and constructive engagement with global regulators, including the US FDA, with a clear focus on achieving a sustainable, fully compliant end state that underpins long-term value creation. Brian Barry will succeed him and lead the next phase of the company's quality transformation; he brings more than 40 years of leadership experience across global Quality, Regulatory Affairs, Medical Safety, and Clinical Affairs. He has demonstrated expertise in strategic planning, organizational development, regulatory compliance, lean transformation, and regulatory agency engagement. With a strong track record in leading complex acquisitions and divestitures, improving quality system performance, and successfully resolving regulatory challenges, Brian will play a key role in further strengthening quality system, advancing patient safety and driving a quality culture. Names and job titles of newly appointed and retiring executive officers: Newly appointed executive officer: Brian Barry: New job titles after August 1, 2026: Executive Officer and Chief Quality Officer. Boris Shkolnik: Current job titles: Executive Officer and Chief Quality Officer. Brian Barry: Date of Birth: August 22, 1959 July 1981: Joined United States Surgical Corporation. September 1988: Quality Assurance Manager, Disposable Products, Corometrics Medical Systems Inc. (acquired by Marquette Electronics). December 1989: Sr. Director, Regulatory Affairs & Quality Assurance, Corometrics Medical Systems Inc. (acquired by Marquette Electronics). July 1994: Vice President, Regulatory Affairs & Quality Assurance, Bard Access Systems Inc. January 1997: Vice President, Corporate Regulatory Affairs, C. R. Bard Inc. December 2000: Vice President, Regulatory, Clinical & Quality Affairs, Medtronic Xomed Inc. September 2003 Vice President, Corporate Regulatory Affairs & Clinical Affairs, C. R. Bard Inc. June 2007: Vice President, Quality, Regulatory, Clinical & Medical Affairs, Medtronic Sofamor Danek USA Inc. September 2013: Vice President, Corporate Regulatory Affair, Covidien plc (acquired by Medtronic plc) February 2015: Group Vice President, Quality, Regulatory Affairs, Medical Safety & Scientific Communications, Minimally Invasive Therapies Group, Medtronic plc February 2021: Vice President, Global Regulatory Shared Services, Medtronic Corporate Regulatory Affairs, Medtronic plc January 2023: Vice President, Medtronic Clinical & Regulatory Solutions, Medtronic plc (present) August 2026: Join Olympus Corporation of the Americas (plan) Executive Officer, Chief Quality Officer, Olympus Corporation (plan) New management team from August 1, 2026: The executive officers are stated by the alphabetical order of last name excluding the representative officer. Bob White: Director, Representative Executive Officer, President and Chief Executive Officer; Brian Barry: Executive Officer, Chief Quality Officer; Simone Berger: Executive Officer, Chief Human Resources Officer; Keith Boettiger: Executive Officer, Gastrointestinal Solutions Division Head; John de Csepel: Executive Officer, Chief Medical Officer; Gabriela Kaynor: Executive Officer, Chief Strategy Officer; Seiji Kuramoto: Executive Officer, Surgical and Interventional Solutions Division Head; Syed Naveed: Executive Officer, Chief Technology Officer; Michael Parenti: Executive Officer, Chief Financial Officer; David Shan: Executive Officer, Chief Manufacturing and Supply Officer; Neil Boyden Tanner: Executive Officer, Global General Counsel.

Japanese (NIKKEI) Medical Equipment Industry Analysis

Industry Valuation and Performance

Industry Trends

Top Stock Gainers and Losers

Latest News

First quarter 2027 earnings: EPS and revenues exceed analyst expectations

First quarter 2027 earnings released: EPS: JP¥114 (vs JP¥101 in 1Q 2026)

First quarter 2027 earnings released: EPS: JP¥55.72 (vs JP¥48.31 in 1Q 2026)

First quarter 2027 earnings released: EPS: JP¥13.50 (vs JP¥18.19 in 1Q 2026)

First quarter 2027 earnings released: EPS: JP¥32.91 (vs JP¥32.84 in 1Q 2026)

Nipro Corporation Receives Fda 510(K) Clearance for Elisio-Hx Dialyzer and Introduces Hds to the United States

Eyeless Needle Expansion And Surgical Pipeline Will Support Stronger Long Term Upside

4543: Dividend Outlook And New Imaging Platform Will Support Balanced Return Potential

Final dividend of JP¥16.00 announced

Final dividend of JP¥20.00 announced

Olympus Corporation Announces Management Changes, Effective August 1, 2026

New major risk - Revenue and earnings growth

New minor risk - Earnings quality

Now 21% overvalued after recent price rise

Upcoming dividend of JP¥30.00 per share

Techno Medica's (TSE:6678) Earnings Offer More Than Meets The Eye